Zusammenfassung
Die Therapie mit Ionenstrahlen bietet, abhängig von der Ionensorte, physikalische sowie biologische Vorteile. Für einige Tumorarten konnte hierbei schon eine klinische Überlegenheit gezeigt werden. Eine Reihe von Studienprotokollen für verschiedene Indikationsbereiche hat bereits die Rekrutierung begonnen. Hierbei soll der Stellenwert der Partikeltherapie in der modernen Radioonkologie erarbeitet werden.
Abstract
Ion beam therapy offers both physical and biological advantages, depending on the type of ion beam used. Its clinical superiority could already be demonstrated for some tumour types. A series of study protocols for various indication areas have already started recruiting with the aim of determining the value of particle therapy in modern radiation oncology.
Literatur
Combs SE, Schulz-Ertner D, Herfarth KK et al (2006) Fortschritte in der Radioonkologie. Von der Präzisionsstrahlentherapie mit Photonen zur Ionentherapie mit Kohlenstoffionen. Chirurg 77:1126–1132
Schulz-Ertner D, Karger CP, Feuerhake A et al (2007) Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 68:449–457
Takahashi S, Kawase T, Yoshida K et al (2009) Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy. Acta Neurochir (Wien) 151:759–769
Ares C, Hug EB, Lomax AJ et al (2009) Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys 75:1111–1118
Debus J, Schulz-Ertner D, Schad L et al (2000) Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 47:591–596
Combs SE, Bohl J, Elsasser T et al (2009) Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines. Int J Radiat Biol 85:126–137
Elsasser T, Scholz M (2006) Improvement of the local effect model (LEM) – implications of clustered DNA damage. Radiat Prot Dosimetry 122:475–477
Elsasser T, Kramer M, Scholz M (2008) Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo. Int J Radiat Oncol Biol Phys 71:866–872
Haberer T, Becher W, Schardt D, Kraft G (1993) Magnetic scanning system for heavy ion therapy. Nuclear Instruments and Methods in Physics Research A330:296–305
Nikoghosyan AV, Karapanagiotou-Schenkel I, Munter MW et al (2010) Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study (HIT-1-Study). BMC Cancer 10:607
Nikoghosyan AV, Rauch G, Munter MW et al (2010) Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study. BMC Cancer 10:606
Mizoe JE, Tsujii H, Hasegawa A et al (2007) Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 69:390–396
Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466
Combs SE, Kieser M, Rieken S et al (2010) Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial. BMC Cancer 10:478
Combs SE, Edler L, Burkholder I et al (2010) Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial. BMC Cancer 10:615
Combs SE, Burkholder I, Edler L et al (2010) Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial. BMC Cancer 10:533
Bert C, Saito N, Schmidt A et al (2007) Target motion tracking with a scanned particle beam. Med Phys 34:4768–4771
Bert C, Rietzel E (2007) 4D treatment planning for scanned ion beams. Radiat Oncol 2:24
Bert C, Grozinger SO, Rietzel E (2008) Quantification of interplay effects of scanned particle beams and moving targets. Phys Med Biol 53:2253–2265
Bert C, Gemmel A, Saito N, Rietzel E (2009) Gated irradiation with scanned particle beams. Int J Radiat Oncol Biol Phys 73:1270–1275
Bert C, Gemmel A, Saito N et al (2010) Dosimetric precision of an ion beam tracking system. Radiat Oncol 5:61
Rietzel E, Bert C (2010) Respiratory motion management in particle therapy. Med Phys 37:449–460
Interessenkonflikt
Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Combs , S., Debus, J. Partikeltherapie mit Protonen und Schwerionen. Forum (2011). https://doi.org/10.1007/s12312-011-0593-7
Published:
DOI: https://doi.org/10.1007/s12312-011-0593-7